Key Highlights

• Shares traded at $344.31 pre-market, down 10.00% from the $382.56 prior close.

• Third-quarter Revenue was $908.6 million against an estimate of $934.3 million.

• Full-year 2026 growth guidance was lowered to about 30%, from 32% to 34%.

• Axon is investing $1.2 billion in Skydio for a 37% stake.

Axon Enterprise (NASDAQ:AXON) shares were lower in pre-market trading on Friday, November 6, at $344.31, down 10.00%, after the company reported third-quarter 2026 revenue of $908.6 million, below the $934.3 million estimate, and lowered its 2026 outlook. Adjusted EPS was $1.72 against an estimate of $1.90. Management attributed the shortfall to three delayed federal Dedrone deployments worth about $130 million.

The Scottsdale, Arizona-based company is known for its TASER conducted energy devices, body-worn and in-car cameras, and cloud-based digital evidence management. It sells through a direct sales force, distributors and resellers to law enforcement, government, enterprise and consumer customers.

Software Growth, Recurring Revenue and Margins in the Quarter

Revenue rose 28% year over year, and the company said it would have exceeded 30% had a $30 million federal Dedrone deal landed. Software and services grew 43% to $437 million, ARR rose 40% to $1.8 billion, and net revenue retention was 126%. Future contracted bookings total $15.8 billion.

Adjusted EBITDA was $236 million, a 25.9% margin, and adjusted gross Margin was 59.2%. Memory costs are a headwind of roughly 50 basis points this year, peaking in the fourth quarter, and are assumed to remain a headwind through 2027 and 2028 with no material further price increases.

Outlook Lowered to About 30% Growth

Full-year 2026 revenue growth guidance was cut to about 30%, or $3.61 billion to $3.63 billion, from 32% to 34%. Fourth-quarter revenue is guided to $990 million to $1.01 billion, against a consensus of about $1.07 billion, with adjusted EBITDA of $245 million to $250 million. Full-year adjusted EBITDA is implied at $924 million to $929 million, about a 25.6% margin.

Guidance excludes three delayed federal drone deployments of about $130 million, which represent roughly 500 basis points of growth, and full-year growth at the midpoint still exceeds 30%. Free Cash Flow is guided to $350 million to $400 million, down from $450 million, on deliberate inventory investment. Inventory targets are expected in the first or early second quarter of 2027, and the 60% conversion target is expected by 2028.

Skydio Investment and Product Bookings

Axon is investing $1.2 billion in Skydio, about 60% cash and 40% stock, for 37% fully diluted ownership and exclusive U.S. and Canada public safety distribution. It is funded partly by a $1.15 billion convertible raise. Bookings are up more than 20% year to date, AI ARR passed $100 million, Axon Body 5 launches next spring, and newer products have exceeded $1 billion in bookings year to date and could double in the fourth quarter.

Delayed Federal Deployments and Inventory Targets Are the Next Checkpoints

Shares fell 9.81% on Thursday to $382.56, in a session when the Nasdaq Composite fell 5.5%. The sector ETF was flat pre-market. The next reference points are the fourth-quarter range, the timing of the three delayed Dedrone deployments and the inventory targets in early 2027.